Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites

International Journal of Pharmaceutics

Volumn 487, Issue 1-2, 2015, Pages 142-147

  Anraku, Makoto ^a   Hiraga, Ayumu ^a   Iohara, Daisuke ^a   Pipkin, James D ^b   Uekama, Kaneto ^a   Hirayama, Fumitoshi ^a  

^a SOJO UNIVERSITY   (Japan)

^b LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

Chitosan; Extending release; Famotidine; Interpolymer complex; Release control; Sulfobutyl ether cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; CHITOSAN; FAMOTIDINE; ANTIULCER AGENT; BETA CYCLODEXTRIN DERIVATIVE; DELAYED RELEASE FORMULATION; GEL; SBE4-BETA-CYCLODEXTRIN; TABLET;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; RAT; SLOW RELEASE FORMULATION; TABLET DISINTEGRATION; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; DELAYED RELEASE FORMULATION; GEL; MALE; PH; SOLUBILITY; TABLET; WISTAR RAT;

ANIMALS; ANTI-ULCER AGENTS; BETA-CYCLODEXTRINS; CHITOSAN; DELAYED-ACTION PREPARATIONS; FAMOTIDINE; GELS; HYDROGEN-ION CONCENTRATION; KINETICS; MALE; RATS; RATS, WISTAR; SOLUBILITY; TABLETS;

EID: 84927731860     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.022     Document Type: Article

References (21)

1. M. Anraku, D. Iohara, A. Hiraga, K. Uekama, S. Ifuku, J.D. Pipkin, and F. Hirayama Formation of Elastic Gels from Surface-deacetylated Chitin Nanofibers Reinforced with Sulfobutyl Ether β-Cyclodextrin Chem. Lett. 44 2015 285 287
2. J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, and R. Gurny Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications Eur. J. Pharm. Biopharm. 57 2004 19 34
3. G.V. Betageri, D.V. Deshmukh, and R.B. Gupta Oral sustained release bioadhesive tablet formulation of didanosine Drug Dev. Ind. Pharm. 27 2001 129 136
4. M.E. Brewster, and T. Loftsson Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 2007 645 666
5. Coffin, M.D., Parr, A.F., 1995. Ranitidine solid dosage form. US Patent. 5, 407-687.
6. P.M. de la Torre, S. Torrado, and S. Torrado Interpolymer complexes of poly(acrylic acid) and chitosan: influence of the ionic hydrogel-forming medium Biomaterials 224 2003 1459 1468
7. Z. Fülöp, P. Saokham, and T. Loftsson Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics Int. J. Pharm. 472 2014 282 287
8. T. Higuchi Mechanism of sustained- action medication. Theoretical analysis of rate of release of solid drugs. Dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
9. F.M. Mady, A.E. Abou-Taleb, K.A. Khaled, K. Yamasaki, D. Iohara, K. Taguchi, M. Anraku, F. Hirayama, K. Uekama, and M. Otagiri Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine Int. J. Pharm. 397 2010 1 8
10. H. Matsuda, S. Mutsumoto, K. Kaguragi, K. Kurihara, K. Tochigi, and K. Tomono Determination and correlation of solubilities of famotidine in water co-solvent mixed solvents Fluid Phase Equilib. 302 2011 115 122
11. M.J. Moura, H. Faneca, M.P. Lima, M.H. Gil, and M.M. Figueiredo In situ forming chitosan hydrogels prepared via ionic/covalent co-cross-linking Biomacromolecules 12 2011 3275 3284
12. C. Muzzarelli, V. Stanic, L. Gobbi, G. Tosi, and R. Muzzarelli Spray drying of solutions containing chitosan together with polyuronans and characterisation of the microspheres Carbohydr. Polym. 57 2004 73 82
13. L. Noble, A.I. Gray, L. Sadiq, and I.F. Uchegbu A noncovalently cross-linked chitosan based hydrogel Int. J. Pharm. 192 1999 173 182
14. S.H. Park, M.K. Chun, and H.K. Choi Preparation of an extended-release matrix tablet using chitosan/carbopol interpolymer complex Int. J. Pharm. 347 2008 39 44
15. H. Tomida, T. Yasufuku, T. Fujii, Y. Kondo, T. Kai, and M. Anraku Polysaccharides as potential antioxidative compounds for extended-release matrix tablets Carbohydr. Res. 345 2010 82 86
16. C. Scarpignato New drugs to suppress acid secretion: current and future developments Drug Discov. Today Ther. Strateg. 4 2007 155 163
17. S. Sotthivirat, J.L. Haslam, and V.J. Stella Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD Int. J. Pharm. 330 2007 73 81
18. A. Trapani, A. Lopedotam, M. Francom, N. Cioffim, E. Ievam, M. Garcia-Fuentesm, and M.J. Alonsom A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides Eur. J. Pharm. Biopharm. 75 2010 26 32
19. W. Tiyaboonchai, and N. Limpeanchob Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles Int. J. Pharm. 329 2007 142 149
20. C.W. Vendruscolo, I.F. Andreazza, J.L. Ganter, M.S. Ferrero, and T.M.B. Bresolin Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline Int. J. Pharm. 296 2005 1 11
21. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and A. Uno A pharmacokinetic analysis program (multi) for microcomputer J. Pharmacobiodyn. 4 1981 879 885